These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 20799288)
1. New anatomical classification of the axilla with implications for sentinel node biopsy. Clough KB; Nasr R; Nos C; Vieira M; Inguenault C; Poulet B Br J Surg; 2010 Nov; 97(11):1659-65. PubMed ID: 20799288 [TBL] [Abstract][Full Text] [Related]
2. Predictors of non-sentinel lymph node metastasis in breast cancer patients. Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE; Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163 [TBL] [Abstract][Full Text] [Related]
3. Ductal carcinoma in situ: value of sentinel lymph node biopsy. Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457 [TBL] [Abstract][Full Text] [Related]
4. Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment? Port ER; Patil S; Stempel M; Morrow M; Cody HS Cancer; 2010 Apr; 116(8):1987-91. PubMed ID: 20151427 [TBL] [Abstract][Full Text] [Related]
5. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy. Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513 [TBL] [Abstract][Full Text] [Related]
6. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study. Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047 [TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507 [TBL] [Abstract][Full Text] [Related]
8. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202 [TBL] [Abstract][Full Text] [Related]
9. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit. Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346 [TBL] [Abstract][Full Text] [Related]
10. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952 [TBL] [Abstract][Full Text] [Related]
11. Accuracy of sentinel lymph node biopsy for the assessment of axillary status in patients with early (T1) breast carcinoma. Gurleyik G; Aker F; Sekmen U; Saglam A J Coll Physicians Surg Pak; 2005 Nov; 15(11):697-700. PubMed ID: 16300705 [TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy for breast cancer: the role of previous biopsy on patient eligibility. Miner TJ; Shriver CD; Jaques DP; Maniscalco-Theberge ME; Krag DN Am Surg; 1999 Jun; 65(6):493-8; discussion 498-9. PubMed ID: 10366201 [TBL] [Abstract][Full Text] [Related]
13. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery. Changsri C; Prakash S; Sandweiss L; Bose S Breast J; 2004; 10(5):392-7. PubMed ID: 15327491 [TBL] [Abstract][Full Text] [Related]
14. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy? Specht MC; Fey JV; Borgen PI; Cody HS J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914 [TBL] [Abstract][Full Text] [Related]
15. [Importance of sentinel lymph node biopsy in surgical therapy of in situ breast cancer]. Takács T; Szentpáli K; Paszt A; Ormándi K; Lázár M; Pálka I; Kahán Z; Lázár G Magy Onkol; 2006; 50(3):247-51. PubMed ID: 17099786 [TBL] [Abstract][Full Text] [Related]
16. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years. Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841 [TBL] [Abstract][Full Text] [Related]
17. Sentinel node biopsy for breast cancer: does the number of sentinel nodes removed have an impact on the accuracy of finding a positive node? Schrenk P; Rehberger W; Shamiyeh A; Wayand W J Surg Oncol; 2002 Jul; 80(3):130-6. PubMed ID: 12115795 [TBL] [Abstract][Full Text] [Related]
19. The reliability and accuracy of intraoperative imprint cytology of sentinel lymph nodes in breast cancer. Pogacnik A; Klopcic U; Grazio-Frković S; Zgajnar J; Hocevar M; Vidergar-Kralj B Cytopathology; 2005 Apr; 16(2):71-6. PubMed ID: 15787648 [TBL] [Abstract][Full Text] [Related]
20. Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy. King TA; Ganaraj A; Fey JV; Tan LK; Hudis C; Norton L; Cody HS; Borgen PI Cancer; 2004 Sep; 101(5):926-33. PubMed ID: 15329899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]